sertraline Side Effects
Also known as: Zoloft
Analysis of 112,198 adverse event reports submitted to the FDA from 2004 to 2025.
Total Reports
112,198
Death-Related
11,431
10.2% of reports
Hospitalizations
38,447
34.3% of reports
Top Indication
Product Used For Unknown Indication
Most Reported Adverse Reactions
Who Reports Side Effects
Gender Distribution
Age Distribution
Reporting Trend by Year
Reactions in Death Reports
Top reactions reported in 11,431 reports where death was an outcome. These are voluntarily reported and do not establish causation.
| Reaction | Reports |
|---|---|
| DEATH | 2,644 |
| COMPLETED SUICIDE | 2,450 |
| TOXICITY TO VARIOUS AGENTS | 1,769 |
| DRUG ABUSE | 829 |
| CARDIO-RESPIRATORY ARREST | 632 |
| CARDIAC ARREST | 619 |
| DRUG INTERACTION | 472 |
| PNEUMONIA | 467 |
| OVERDOSE | 425 |
| FALL | 422 |
| DYSPNOEA | 409 |
| RESPIRATORY ARREST | 349 |
| SEPSIS | 336 |
| VOMITING | 319 |
| DIARRHOEA | 295 |
| NAUSEA | 290 |
| OFF LABEL USE | 288 |
| FATIGUE | 285 |
| ASTHENIA | 270 |
| SOMNOLENCE | 263 |
Reactions in Hospitalization Reports
Top reactions in 38,447 reports where hospitalization was an outcome.
| Reaction | Reports |
|---|---|
| NAUSEA | 2,263 |
| DRUG INTERACTION | 2,192 |
| VOMITING | 2,181 |
| FALL | 2,166 |
| INTENTIONAL OVERDOSE | 2,008 |
| PNEUMONIA | 1,748 |
| DRUG INEFFECTIVE | 1,672 |
| OFF LABEL USE | 1,670 |
| DYSPNOEA | 1,667 |
| FATIGUE | 1,634 |
| TOXICITY TO VARIOUS AGENTS | 1,605 |
| DIARRHOEA | 1,604 |
| CONFUSIONAL STATE | 1,471 |
| DIZZINESS | 1,467 |
| ANXIETY | 1,438 |
| HEADACHE | 1,404 |
| SUICIDE ATTEMPT | 1,398 |
| ASTHENIA | 1,360 |
| CONDITION AGGRAVATED | 1,259 |
| DEPRESSION | 1,243 |
Nearby — Related Medications
What the FAERS Data Reveals About sertraline Side Effects
The FDA Adverse Event Reporting System (FAERS) contains 112,198 voluntary reports linked to sertraline and its brand equivalents (Zoloft), spanning 2004 through 2025. Of those, 11,431 (10.2%) listed death as an outcome and 38,447 (34.3%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.
Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 64% were female and 35% male; age distribution skews toward 18-44, with 25,942 reports in that bracket. The single most reported reaction is drug ineffective with 6,804 submissions, followed by nausea and fatigue.
FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice — speak with a licensed clinician about any side-effect concerns.
Read our methodology — how this data is sourced, computed, and verified.